Related references
Note: Only part of the references are listed.Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
Andrey I. Khramtsov et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers
Rachael Natrajan et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Cytoplasmic Localization of beta-Catenin is a Marker of Poor Outcome in Breast Cancer Patients
Elena Lopez-Knowles et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Nuclear β-catenin expression and Wnt signalling: in defence of the dogma
Riccardo Fodde et al.
JOURNAL OF PATHOLOGY (2010)
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study
Maryou B. Lambros et al.
MODERN PATHOLOGY (2010)
Most Basal-like Breast Carcinomas Demonstrate the Same Rb-/p16+Immunophenotype as the HPV-related Poorly Differentiated Squamous Cell Carcinomas Which They Resemble Morphologically
Andrea Proctor Subhawong et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis
Britta Weigelt et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Patho-biological aspects of basal-like breast cancer
Emad A. Rakha et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Bryan T. Hennessy et al.
CANCER RESEARCH (2009)
Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
Rachael Natrajan et al.
CLINICAL CANCER RESEARCH (2009)
APC and the three-hit hypothesis
S. Segditsas et al.
ONCOGENE (2009)
Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors
Alexander J. F. Lazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype
David Sarrió et al.
CANCER RESEARCH (2008)
Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast
Michael J. Hayes et al.
CLINICAL CANCER RESEARCH (2008)
Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype
B. Mahler-Araujo et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Nestin is expressed in basal-like and triple negative breast cancers
S. Parry et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Refinement of breast cancer classification by molecular characterization of histological special types
B. Weigelt et al.
JOURNAL OF PATHOLOGY (2008)
Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast
C. Marchio et al.
JOURNAL OF PATHOLOGY (2008)
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
Edurne Arriola et al.
LABORATORY INVESTIGATION (2008)
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis
Kay Savage et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
David S. P. Tan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition
H. C. Lien et al.
ONCOGENE (2007)
Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: A morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis
Kay Savage et al.
CLINICAL CANCER RESEARCH (2007)
Metaplastic breast carcinomas are basal-like tumours
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2006)
Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas:: an immunohistochemical and chromogenic in situ hybridisation analysis
Jorge S. Reis-Filho et al.
MODERN PATHOLOGY (2006)
Quantitative in situ analysis of β-catenin expression in breast cancer shows decreased expression is associated with poor outcome
Marisa Dolled-Filhart et al.
CANCER RESEARCH (2006)
Breast cancer staging: Working with the sixth edition of the AJCC Cancer Staging Manual
SE Singletary et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2006)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
β-catenin and p53 analyses of a breast carcinoma tissue microarray
GG Chung et al.
CANCER (2004)
β-catenin and Tcfs in mammary development and cancer
S Hatsell et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2003)
Wnt signaling in hepatocellular carcinoma: Analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes
J Cui et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies
KB Pedersen et al.
BRITISH JOURNAL OF CANCER (2002)
β-catenin interacts with and inhibits NF-κB in human colon and breast cancer
JO Deng et al.
CANCER CELL (2002)
Target disruption of the mutant β-catenin gene in colon cancer cell line HCT116:: preservation of its malignant phenotype
S Sekine et al.
ONCOGENE (2002)
Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours
SCC Wong et al.
JOURNAL OF PATHOLOGY (2002)
Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway
SC Abraham et al.
HUMAN PATHOLOGY (2002)
Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast
CE Gillett et al.
JOURNAL OF PATHOLOGY (2001)
β-catenin, a novel prognostic marker for breast cancer:: Its roles in cyclin D1 expression and cancer progression
SY Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)